These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3832931)

  • 1. [Clinical effectiveness of KL 007 (oxybutynin hydrochloride) in urinary disorders].
    Takimoto Y; Kiyotaki S; Kawazoe K; Fuse T; Kitamura K; Yamamoto T; Satoh Y; Okada K; Kishimoto T
    Hinyokika Kiyo; 1985 Dec; 31(12):2284-301. PubMed ID: 3832931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H; Nakamura R
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of oxybutynin hydrochloride (1 mg/tablet)].
    Yokoyama E; Fujino A; Kubo S; Mashimo S; Koshiba K
    Hinyokika Kiyo; 1990 Jul; 36(7):869-76. PubMed ID: 2239587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies of terodiline hydrochloride and clenbuterol hydrochloride for urinary frequency and incontinence].
    Katsumi T; Murayama K; Tajika E; Nakamura T; Kawaguchi K
    Hinyokika Kiyo; 1991 Nov; 37(11):1575-80. PubMed ID: 1767784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K; Shiomi T; Momose H; Yamamoto M; Okamura K; Suemori T
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
    Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
    Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
    Yoneyama T; Ogawa A; Fukui J; Wajiki M; Tomita Y; Igawa Y; Yanagisawa A; Uchiyama S; Watanabe K; Aida Y
    Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term therapy with Robaveron tablet (KN-7) for urinary disturbance].
    Tei K; Doi T; Sakai S; Fujimoto Y; Ban Y
    Hinyokika Kiyo; 1985 Apr; 31(4):731-8. PubMed ID: 2412422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
    Malone-Lee J; Shaffu B; Anand C; Powell C
    J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
    Sugiyama T; Kiwamoto H; Uchida A; Nagai N; Park YC; Kurita T; Ikegami M; Nakanishi A; Kawamura M; Umekawa T
    Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances].
    Nakano M; Tajima A; Aso Y; Suzuki K; Hata M; Tsukada T; Masuda H; Hirose J; Kitagawa M; Nakahara M
    Hinyokika Kiyo; 1988 Jan; 34(1):196-200. PubMed ID: 3376801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect of Robaveron tablet (KN-7) on neurogenic bladder].
    Endo H; Sonoda T; Koyanagi T; Maru A; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1984 Jan; 30(1):135-44. PubMed ID: 6375318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.